Usmani, S. Z., Nahi, H., Legiec, W., Grosicki, S., Vorobyev, V., Spicka, I., Hungria, V., Korenkova, S., Bahlis, N. J., Flogegard, M., Bladé, J., Moreau, P., Kaiser, M., Iida, S., Laubach, J., Magen, H., Cavo, M., Hulin, C., White, D., De Stefano, V., Lantz, K., O’Rourke, L., Heuck, C., Delioukina, M., Qin, X., Nnane, I., Qi, M. and Mateos, M.-V. (2022) “Final analysis of the phase III non-inferiority COLUMBA study of subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma”, Haematologica. Pavia, Italy, 107(10), pp. 2408-2417. doi: 10.3324/haematol.2021.279459.